Core Data Elements
Number of Cases
573Case Sex
Female (188); Male (218); Not Reported (167)
Case Age At Diagnosis
0 to 4 years (114); 5 to 9 years (109); 10 to 14 years (67); 15 to 19 years (44); 20 to 24 years (8); 25 to 29 years (2); Pediatric and Young Adult (<40 years) (229)
Case Race
Not Reported (573)
Case Ethnicity
Not Reported (573)
Case Disease Diagnosis
Adrenal Carcinoma (METS) (1); Adrenocortical Carcinoma (2); Anaplastic Astrocytoma (20); Anaplastic Embryonal Rhabdomyosarcoma (1); Anaplastic Ependymoma (4); Anaplastic Medulloblastoma (2); Astrocytoma (Pilomyxoid Astrocytoma) (1); Atypical Teratoid Rhabdoid Tumour (ATRT) (32); Carcinoma (Adult), Colon (3); Cholangiocarcinoma (1); Chordoma (10); Choroid Plexus Carcinoma (4); Clear Cell Sarcoma (5); Craniopharyngioma (2); Desmoplastic Small Round Cell Tumour (2); Diffuse Leptomeningeal Glioneuronal Tumour (1); Diffuse Midline Glioma (DMG) (124); Dysgerminoma (2); Embryonal Rhabdomyosarcoma (1); Embryonal Tumour with Multilayered Rosettes (ETMR) (5); Ependymoma (22); Ewing's Sarcoma (24); Ewing's Sarcoma (MET) (1); Ganglioglioma (2); Ganglioneuroblastoma (GNB) (3); Ganglioneuroblastoma (Intermixed Subtype) (1); Germ Cell Tumour (2); Glioblastoma (45); Glioblastoma (Adult) (19); Glioma (3); Hepatoblastoma (2); High Grade Glioma (HGG) (34); Inflammatory Myofibroblastic Tumour (IMFT) (2); Juvenile Ossifying Fibroma (1); Low Grade Neoplasm (1); Lung Carcinoid Tumour (Benign) (1); Malignant Peripheral Nerve Sheath Tumour (1); Malignant Rhabdoid Tumour (MRT) (3); Medulloblastoma (25); Medulloblastoma (WHO Grade IV) (1); Mesothelioma (1); Mixed Glioma (1); Muco-Epidermoid Carcinoma (1); Nasopharyngeal Carcinoma (2); Neuroblastoma (47); Neuroblastoma (PDX) (13); No Malignancy, Brain (17); No Malignancy, Kidney (3); Oligodendroglioma (5); Osteosarcoma (24); Pilocytic Astrocytoma (5); Pleomorphic Xanthroastrocytoma (1); Primitive Neuroectodermal Tumour (PNET) (4); Retinoblastoma (1); Rhabdomyosarcoma (28); Rhabdomyosarcoma (Embryonal, Recurrent) (2); Subependymal Giant Cell Astrocytoma (1); Not Reported (1)
Case Tumor Site
Abdomen (3); Adrenal Gland (1); Bone (20); Bone (Rare) (2); Bone Marrow (3); Brain (273); Brain (Rare) (1); Clival Chrodoma (3); Colon (3); Fibular (1); Kidney (16); Liver (1); Lung (2); Nasal Cavity (2); Ovary (1); Parotid Gland (1); Pelvis (1); Pineal Gland (1); Scalp (1); Soft Tissue (5); Spinal Cord (1); Spine (2); Not Reported (229)
Number of Samples
1,523Sample Assay Method
ATAC Sequencing (17); CRISPR Screens (149); DNA Methylation (203); Drug Screens (548); Proteomics (142); RNA Sequencing (248); Whole Genome Sequencing (216)